AMO (Advanced Medical Optics) closes Pfizer deal:
This article was originally published in Clinica
Advanced Medical Optics (AMO) has completed the purchase of Pfizer's ophthalmic surgical business. Santa Ana, California-based AMO had agreed at the end of April this year to acquire the Pfizer unit in a $450m all-cash transaction (see Clinica No 1105, p 19). Through this deal, AMO's portfolio will be significantly boosted with the addition of Pfizer's CeeOn and Tecnis lines of intraocular lenses, its Healon family of viscoelastic products and the Baerveldt glaucoma shunt.